In this context, very limited evidence has shown that PSG9 protein levels are significantly increased in hepatocellular carcinoma and colorectal cancer patients and could serve as an indicator of patient prognosis.50, 56, 57, 58, 59. This evidence concerns the gene PSG9 and colorectal cancer.